25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Surgical Science Sweden AB
Buy, Hold or Sell?

Let's analyze Surgical Science Sweden AB together

I guess you are interested in Surgical Science Sweden AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Surgical Science Sweden AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Surgical Science Sweden AB

I send you an email if I find something interesting about Surgical Science Sweden AB.

1. Quick Overview

1.1. Quick analysis of Surgical Science Sweden AB (30 sec.)










1.2. What can you expect buying and holding a share of Surgical Science Sweden AB? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr90.02
Expected worth in 1 year
kr92.29
How sure are you?
64.7%

+ What do you gain per year?

Total Gains per Share
kr2.27
Return On Investment
1.8%

For what price can you sell your share?

Current Price per Share
kr126.50
Expected price per share
kr111.80 - kr154.40
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Surgical Science Sweden AB (5 min.)




Live pricePrice per Share (EOD)
kr126.50
Intrinsic Value Per Share
kr28.31 - kr33.09
Total Value Per Share
kr118.33 - kr123.11

2.2. Growth of Surgical Science Sweden AB (5 min.)




Is Surgical Science Sweden AB growing?

Current yearPrevious yearGrowGrow %
How rich?$455.1m$429.1m$17.9m4.0%

How much money is Surgical Science Sweden AB making?

Current yearPrevious yearGrowGrow %
Making money$4.8m$5.7m-$889.5k-18.2%
Net Profit Margin22.9%25.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Surgical Science Sweden AB (5 min.)




2.4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  


Richest
#22 / 109

Most Revenue
#49 / 109

Most Profit
#17 / 109
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Surgical Science Sweden AB?

Welcome investor! Surgical Science Sweden AB's management wants to use your money to grow the business. In return you get a share of Surgical Science Sweden AB.

First you should know what it really means to hold a share of Surgical Science Sweden AB. And how you can make/lose money.

Speculation

The Price per Share of Surgical Science Sweden AB is kr126.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Surgical Science Sweden AB.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Surgical Science Sweden AB, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr90.02. Based on the TTM, the Book Value Change Per Share is kr0.57 per quarter. Based on the YOY, the Book Value Change Per Share is kr2.25 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Surgical Science Sweden AB.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.060.0%0.100.1%0.110.1%0.060.0%0.030.0%
Usd Book Value Change Per Share0.010.0%0.060.0%0.220.2%0.440.3%0.260.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.0%0.060.0%0.220.2%0.440.3%0.260.2%
Usd Price Per Share12.40-15.10-17.98-18.47-13.28-
Price to Earnings Ratio55.86-50.35-52.01--267.48--251.68-
Price-to-Total Gains Ratio1,284.90-361.37-140.01-572.51-48.52-
Price to Book Ratio1.39-1.73-2.13-10.13-21.92-
Price-to-Total Gains Ratio1,284.90-361.37-140.01-572.51-48.52-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share12.53615
Number of shares79
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.060.44
Usd Total Gains Per Share0.060.44
Gains per Quarter (79 shares)4.4534.68
Gains per Year (79 shares)17.78138.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101880139129
2036260277268
3053440416407
4071620555546
5089800694685
60107980832824
701241160971963
80142134011101102
90160152012491241
100178170013871380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%18.02.00.090.0%21.013.00.061.8%21.013.00.061.8%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%18.02.00.090.0%22.09.03.064.7%22.09.03.064.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.034.00.0%0.00.034.00.0%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%18.02.00.090.0%22.09.03.064.7%22.09.03.064.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Surgical Science Sweden AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0970.568-83%2.254-96%4.430-98%2.648-96%
Book Value Per Share--90.01788.416+2%84.868+6%52.925+70%31.570+185%
Current Ratio--4.1493.952+5%2.801+48%3.381+23%3.319+25%
Debt To Asset Ratio--0.0740.077-3%0.091-19%0.109-31%0.147-49%
Debt To Equity Ratio--0.0800.083-3%0.101-20%0.124-35%0.235-66%
Dividend Per Share----0%-0%-0%-0%
Eps--0.5600.969-42%1.145-51%0.584-4%0.337+66%
Free Cash Flow Per Share--0.3430.492-30%0.949-64%0.382-10%0.219+56%
Free Cash Flow To Equity Per Share--0.2120.466-54%1.055-80%3.469-94%2.059-90%
Gross Profit Margin---0.480-0.099-79%0.116-515%2.344-120%2.258-121%
Intrinsic Value_10Y_max--33.090--------
Intrinsic Value_10Y_min--28.309--------
Intrinsic Value_1Y_max--2.466--------
Intrinsic Value_1Y_min--2.422--------
Intrinsic Value_3Y_max--8.057--------
Intrinsic Value_3Y_min--7.679--------
Intrinsic Value_5Y_max--14.429--------
Intrinsic Value_5Y_min--13.337--------
Market Cap6454814300.000+1%6383382123.6007776398366.400-18%9256152680.000-31%9510391818.780-33%6836310828.988-7%
Net Profit Margin--0.1340.229-41%0.250-46%0.190-29%0.049+173%
Operating Margin--0.1480.169-13%0.213-31%0.117+26%-0.008+106%
Operating Ratio--0.8520.814+5%0.774+10%0.819+4%0.961-11%
Pb Ratio1.405+1%1.3901.729-20%2.131-35%10.125-86%21.924-94%
Pe Ratio56.486+1%55.86150.353+11%52.009+7%-267.479+579%-251.677+551%
Price Per Share126.500+1%125.100152.400-18%181.400-31%186.383-33%133.976-7%
Price To Free Cash Flow Ratio92.206+1%91.18683.388+9%-794.964+972%-6.291+107%-8.030+109%
Price To Total Gains Ratio1299.279+1%1284.900361.371+256%140.007+818%572.505+124%48.525+2548%
Quick Ratio--3.0953.077+1%2.109+47%2.596+19%2.574+20%
Return On Assets--0.0060.010-44%0.012-53%0.010-43%0.007-12%
Return On Equity--0.0060.011-44%0.014-54%0.011-45%0.004+67%
Total Gains Per Share--0.0970.568-83%2.254-96%4.430-98%2.648-96%
Usd Book Value--455191174.100447094654.550+2%429151509.450+6%267627453.225+70%159637508.471+185%
Usd Book Value Change Per Share--0.0100.056-83%0.223-96%0.439-98%0.262-96%
Usd Book Value Per Share--8.9218.762+2%8.410+6%5.245+70%3.129+185%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0550.096-42%0.113-51%0.058-4%0.033+66%
Usd Free Cash Flow--1734349.1002489268.125-30%4800825.175-64%1929442.315-10%1108477.221+56%
Usd Free Cash Flow Per Share--0.0340.049-30%0.094-64%0.038-10%0.022+56%
Usd Free Cash Flow To Equity Per Share--0.0210.046-54%0.105-80%0.344-94%0.204-90%
Usd Market Cap639672097.130+1%632593168.449770641078.110-18%917284730.588-31%942479829.241-33%677478403.153-7%
Usd Price Per Share12.536+1%12.39715.103-18%17.977-31%18.471-33%13.277-7%
Usd Profit--2831088.8004898612.100-42%5788208.025-51%2951123.675-4%1705921.974+66%
Usd Revenue--21055380.60020767594.200+1%22309912.275-6%13027819.785+62%8261646.382+155%
Usd Total Gains Per Share--0.0100.056-83%0.223-96%0.439-98%0.262-96%
 EOD+4 -4MRQTTM+11 -23YOY+10 -245Y+12 -2210Y+21 -13

3.3 Fundamental Score

Let's check the fundamental score of Surgical Science Sweden AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1556.486
Price to Book Ratio (EOD)Between0-11.405
Net Profit Margin (MRQ)Greater than00.134
Operating Margin (MRQ)Greater than00.148
Quick Ratio (MRQ)Greater than13.095
Current Ratio (MRQ)Greater than14.149
Debt to Asset Ratio (MRQ)Less than10.074
Debt to Equity Ratio (MRQ)Less than10.080
Return on Equity (MRQ)Greater than0.150.006
Return on Assets (MRQ)Greater than0.050.006
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Surgical Science Sweden AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.977
Ma 20Greater thanMa 50120.135
Ma 50Greater thanMa 100125.862
Ma 100Greater thanMa 200130.741
OpenGreater thanClose128.000
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Surgical Science Sweden AB

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room. In addition, the company offers PELVIC Mentor simulator provides anatomy and pelvic exam training; Perc Mentor suite for image-guided interventions; RobotiX Mentor for practice the motor and cognitive skills for surgeons; Simball Box, which combines with digitally collected metrics into a powerful training tool; Spine Mentor, a training simulator for minimal invasive spine surgery; TEE Express, designed to teach Trans-Esophageal Echocardiography procedure using a TEE probe; TraumaVR, an ultimate mix of manikin and VR simulation; and Ultrasound Mentor for ultrasound training with multiple medical specialties. Surgical Science AB was incorporated in 1997 and is headquartered in Gothenburg, Sweden.

Fundamental data was last updated by Penke on 2024-09-25 06:32:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is overpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Surgical Science Sweden AB earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Surgical Science Sweden AB to the Health Information Services industry mean.
  • A Net Profit Margin of 13.4% means that kr0.13 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Surgical Science Sweden AB:

  • The MRQ is 13.4%. The company is making a huge profit. +2
  • The TTM is 22.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ13.4%TTM22.9%-9.5%
TTM22.9%YOY25.0%-2.1%
TTM22.9%5Y19.0%+3.9%
5Y19.0%10Y4.9%+14.1%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ13.4%-21.3%+34.7%
TTM22.9%-23.3%+46.2%
YOY25.0%-23.1%+48.1%
5Y19.0%-31.1%+50.1%
10Y4.9%-43.1%+48.0%
4.3.1.2. Return on Assets

Shows how efficient Surgical Science Sweden AB is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Surgical Science Sweden AB to the Health Information Services industry mean.
  • 0.6% Return on Assets means that Surgical Science Sweden AB generated kr0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Surgical Science Sweden AB:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.6%TTM1.0%-0.4%
TTM1.0%YOY1.2%-0.2%
TTM1.0%5Y1.0%+0.0%
5Y1.0%10Y0.7%+0.4%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6%-4.6%+5.2%
TTM1.0%-4.7%+5.7%
YOY1.2%-4.7%+5.9%
5Y1.0%-4.9%+5.9%
10Y0.7%-5.9%+6.6%
4.3.1.3. Return on Equity

Shows how efficient Surgical Science Sweden AB is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Surgical Science Sweden AB to the Health Information Services industry mean.
  • 0.6% Return on Equity means Surgical Science Sweden AB generated kr0.01 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Surgical Science Sweden AB:

  • The MRQ is 0.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.6%TTM1.1%-0.5%
TTM1.1%YOY1.4%-0.2%
TTM1.1%5Y1.1%0.0%
5Y1.1%10Y0.4%+0.8%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6%-3.0%+3.6%
TTM1.1%-5.6%+6.7%
YOY1.4%-5.8%+7.2%
5Y1.1%-8.6%+9.7%
10Y0.4%-9.2%+9.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Surgical Science Sweden AB.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Surgical Science Sweden AB is operating .

  • Measures how much profit Surgical Science Sweden AB makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Surgical Science Sweden AB to the Health Information Services industry mean.
  • An Operating Margin of 14.8% means the company generated kr0.15  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Surgical Science Sweden AB:

  • The MRQ is 14.8%. The company is operating less efficient.
  • The TTM is 16.9%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ14.8%TTM16.9%-2.1%
TTM16.9%YOY21.3%-4.4%
TTM16.9%5Y11.7%+5.2%
5Y11.7%10Y-0.8%+12.6%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ14.8%-16.3%+31.1%
TTM16.9%-22.0%+38.9%
YOY21.3%-19.0%+40.3%
5Y11.7%-15.6%+27.3%
10Y-0.8%-24.0%+23.2%
4.3.2.2. Operating Ratio

Measures how efficient Surgical Science Sweden AB is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 0.85 means that the operating costs are kr0.85 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Surgical Science Sweden AB:

  • The MRQ is 0.852. The company is less efficient in keeping operating costs low.
  • The TTM is 0.814. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.852TTM0.814+0.038
TTM0.814YOY0.774+0.041
TTM0.8145Y0.819-0.004
5Y0.81910Y0.961-0.142
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8521.278-0.426
TTM0.8141.303-0.489
YOY0.7741.388-0.614
5Y0.8191.305-0.486
10Y0.9611.313-0.352
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Surgical Science Sweden AB.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Surgical Science Sweden AB is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 4.15 means the company has kr4.15 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Surgical Science Sweden AB:

  • The MRQ is 4.149. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.952. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.149TTM3.952+0.197
TTM3.952YOY2.801+1.151
TTM3.9525Y3.381+0.571
5Y3.38110Y3.319+0.061
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1491.662+2.487
TTM3.9521.800+2.152
YOY2.8011.924+0.877
5Y3.3812.646+0.735
10Y3.3192.676+0.643
4.4.3.2. Quick Ratio

Measures if Surgical Science Sweden AB is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Surgical Science Sweden AB to the Health Information Services industry mean.
  • A Quick Ratio of 3.10 means the company can pay off kr3.10 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Surgical Science Sweden AB:

  • The MRQ is 3.095. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.077. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.095TTM3.077+0.018
TTM3.077YOY2.109+0.969
TTM3.0775Y2.596+0.482
5Y2.59610Y2.574+0.022
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0951.298+1.797
TTM3.0771.313+1.764
YOY2.1091.388+0.721
5Y2.5962.281+0.315
10Y2.5742.424+0.150
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Surgical Science Sweden AB.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Surgical Science Sweden AB assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Surgical Science Sweden AB to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.07 means that Surgical Science Sweden AB assets are financed with 7.4% credit (debt) and the remaining percentage (100% - 7.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Surgical Science Sweden AB:

  • The MRQ is 0.074. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.077. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.074TTM0.077-0.002
TTM0.077YOY0.091-0.015
TTM0.0775Y0.109-0.032
5Y0.10910Y0.147-0.039
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0740.403-0.329
TTM0.0770.405-0.328
YOY0.0910.415-0.324
5Y0.1090.418-0.309
10Y0.1470.428-0.281
4.5.4.2. Debt to Equity Ratio

Measures if Surgical Science Sweden AB is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Surgical Science Sweden AB to the Health Information Services industry mean.
  • A Debt to Equity ratio of 8.0% means that company has kr0.08 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Surgical Science Sweden AB:

  • The MRQ is 0.080. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.083. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.080TTM0.083-0.003
TTM0.083YOY0.101-0.018
TTM0.0835Y0.124-0.041
5Y0.12410Y0.235-0.111
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0800.593-0.513
TTM0.0830.599-0.516
YOY0.1010.643-0.542
5Y0.1240.652-0.528
10Y0.2350.678-0.443
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Surgical Science Sweden AB generates.

  • Above 15 is considered overpriced but always compare Surgical Science Sweden AB to the Health Information Services industry mean.
  • A PE ratio of 55.86 means the investor is paying kr55.86 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Surgical Science Sweden AB:

  • The EOD is 56.486. Based on the earnings, the company is expensive. -2
  • The MRQ is 55.861. Based on the earnings, the company is expensive. -2
  • The TTM is 50.353. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD56.486MRQ55.861+0.625
MRQ55.861TTM50.353+5.509
TTM50.353YOY52.009-1.656
TTM50.3535Y-267.479+317.832
5Y-267.47910Y-251.677-15.802
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD56.486-0.927+57.413
MRQ55.861-1.363+57.224
TTM50.353-1.676+52.029
YOY52.009-2.552+54.561
5Y-267.479-6.148-261.331
10Y-251.677-4.106-247.571
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Surgical Science Sweden AB:

  • The EOD is 92.206. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 91.186. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 83.388. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD92.206MRQ91.186+1.020
MRQ91.186TTM83.388+7.798
TTM83.388YOY-794.964+878.352
TTM83.3885Y-6.291+89.679
5Y-6.29110Y-8.030+1.739
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD92.206-1.399+93.605
MRQ91.186-2.057+93.243
TTM83.388-1.043+84.431
YOY-794.964-4.474-790.490
5Y-6.291-6.507+0.216
10Y-8.030-4.272-3.758
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Surgical Science Sweden AB is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 1.39 means the investor is paying kr1.39 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Surgical Science Sweden AB:

  • The EOD is 1.405. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.390. Based on the equity, the company is underpriced. +1
  • The TTM is 1.729. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.405MRQ1.390+0.016
MRQ1.390TTM1.729-0.339
TTM1.729YOY2.131-0.402
TTM1.7295Y10.125-8.396
5Y10.12510Y21.924-11.799
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD1.4051.623-0.218
MRQ1.3901.761-0.371
TTM1.7291.822-0.093
YOY2.1312.618-0.487
5Y10.1254.236+5.889
10Y21.9244.266+17.658
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in SEK. All numbers in thousands.

Summary
Total Assets4,962,972
Total Liabilities369,721
Total Stockholder Equity4,593,251
 As reported
Total Liabilities 369,721
Total Stockholder Equity+ 4,593,251
Total Assets = 4,962,972

Assets

Total Assets4,962,972
Total Current Assets1,063,428
Long-term Assets3,899,544
Total Current Assets
Cash And Cash Equivalents 667,075
Net Receivables 126,307
Inventory 177,767
Other Current Assets 92,279
Total Current Assets  (as reported)1,063,428
Total Current Assets  (calculated)1,063,428
+/-0
Long-term Assets
Property Plant Equipment 75,427
Goodwill 3,502,568
Intangible Assets 300,986
Long-term Assets  (as reported)3,899,544
Long-term Assets  (calculated)3,878,981
+/- 20,563

Liabilities & Shareholders' Equity

Total Current Liabilities256,325
Long-term Liabilities113,396
Total Stockholder Equity4,593,251
Total Current Liabilities
Other Current Liabilities 256,325
Total Current Liabilities  (as reported)256,325
Total Current Liabilities  (calculated)256,325
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)113,396
Long-term Liabilities  (calculated)0
+/- 113,396
Total Stockholder Equity
Common Stock2,251
Retained Earnings 560,123
Accumulated Other Comprehensive Income 632,456
Other Stockholders Equity 3,398,421
Total Stockholder Equity (as reported)4,593,251
Total Stockholder Equity (calculated)4,593,251
+/-0
Other
Capital Stock2,251
Cash and Short Term Investments 667,075
Common Stock Shares Outstanding 51,026
Liabilities and Stockholders Equity 4,962,972
Net Debt -667,075
Net Invested Capital 4,592,951
Net Working Capital 807,103



6.2. Balance Sheets Structured

Currency in SEK. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
> Total Assets 
0
0
0
63,700
60,200
93,900
93,400
98,920
94,100
92,300
90,800
99,659
101,036
99,197
453,663
456,213
459,298
461,342
458,501
472,273
963,152
961,805
3,800,002
3,978,133
4,088,074
4,447,242
4,823,732
4,649,563
4,668,513
4,925,394
4,920,203
4,702,673
4,959,080
4,962,972
4,962,9724,959,0804,702,6734,920,2034,925,3944,668,5134,649,5634,823,7324,447,2424,088,0743,978,1333,800,002961,805963,152472,273458,501461,342459,298456,213453,66399,197101,03699,65990,80092,30094,10098,92093,40093,90060,20063,700000
   > Total Current Assets 
2,026
0
0
27,200
23,900
58,100
54,900
59,547
55,100
51,200
50,400
59,807
59,392
57,606
106,977
112,772
116,433
118,052
117,544
133,394
327,413
327,215
544,706
616,909
659,606
704,131
781,671
826,371
880,079
976,130
972,380
991,192
1,044,252
1,063,428
1,063,4281,044,252991,192972,380976,130880,079826,371781,671704,131659,606616,909544,706327,215327,413133,394117,544118,052116,433112,772106,97757,60659,39259,80750,40051,20055,10059,54754,90058,10023,90027,200002,026
       Cash And Cash Equivalents 
-2,026
0
0
3,800
1,600
36,400
29,700
38,536
37,100
26,100
29,300
38,497
39,640
34,500
67,464
69,217
68,556
68,441
74,652
87,157
263,722
267,341
310,599
316,680
329,915
362,253
370,106
433,733
482,079
574,421
606,060
634,366
659,182
667,075
667,075659,182634,366606,060574,421482,079433,733370,106362,253329,915316,680310,599267,341263,72287,15774,65268,44168,55669,21767,46434,50039,64038,49729,30026,10037,10038,53629,70036,4001,6003,80000-2,026
       Short-term Investments 
4,052
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000004,052
       Net Receivables 
0
0
0
12,922
12,300
11,900
12,100
8,154
6,200
13,900
10,800
11,269
8,994
12,451
11,749
17,065
10,331
9,851
9,913
18,590
32,791
26,689
91,562
111,000
121,000
133,000
171,000
244,125
180,791
156,657
140,353
191,708
139,278
126,307
126,307139,278191,708140,353156,657180,791244,125171,000133,000121,000111,00091,56226,68932,79118,5909,9139,85110,33117,06511,74912,4518,99411,26910,80013,9006,2008,15412,10011,90012,30012,922000
       Other Current Assets 
0
0
0
17,500
17,000
14,800
15,200
12,569
10,000
17,700
15,100
16,561
14,219
18,564
33,054
36,367
38,340
34,687
26,988
33,778
44,574
41,397
113,478
187,122
212,381
209,671
97,190
13,630
71,546
69,112
54,720
10,667
77,012
92,279
92,27977,01210,66754,72069,11271,54613,63097,190209,671212,381187,122113,47841,39744,57433,77826,98834,68738,34036,36733,05418,56414,21916,56115,10017,70010,00012,56915,20014,80017,00017,500000
   > Long-term Assets 
-2,026
0
0
36,500
36,400
35,800
38,500
39,373
39,000
41,100
40,400
39,852
41,644
41,591
346,686
343,441
342,865
343,290
340,957
338,879
635,739
634,590
3,255,296
3,361,224
3,428,468
3,743,111
4,042,061
3,823,192
3,788,435
3,949,265
3,947,823
3,711,481
3,914,828
3,899,544
3,899,5443,914,8283,711,4813,947,8233,949,2653,788,4353,823,1924,042,0613,743,1113,428,4683,361,2243,255,296634,590635,739338,879340,957343,290342,865343,441346,68641,59141,64439,85240,40041,10039,00039,37338,50035,80036,40036,50000-2,026
       Property Plant Equipment 
0
0
0
1,400
1,700
2,400
2,300
3,034
3,300
3,500
3,400
3,627
6,426
7,338
10,312
9,071
8,406
7,746
6,560
8,548
20,425
19,759
37,872
38,393
38,551
39,254
40,597
51,358
46,224
45,772
43,275
76,618
75,274
75,427
75,42775,27476,61843,27545,77246,22451,35840,59739,25438,55138,39337,87219,75920,4258,5486,5607,7468,4069,07110,3127,3386,4263,6273,4003,5003,3003,0342,3002,4001,7001,400000
       Goodwill 
0
0
0
0
0
0
3,500
3,373
3,300
4,700
4,600
5,050
5,050
5,050
260,492
260,492
260,492
260,492
260,492
260,492
497,280
497,280
3,084,235
3,019,238
3,091,767
3,383,178
3,659,067
3,444,289
3,424,121
3,575,775
3,572,770
3,328,683
3,517,654
3,502,568
3,502,5683,517,6543,328,6833,572,7703,575,7753,424,1213,444,2893,659,0673,383,1783,091,7673,019,2383,084,235497,280497,280260,492260,492260,492260,492260,492260,4925,0505,0505,0504,6004,7003,3003,3733,500000000
       Intangible Assets 
0
0
0
31,400
31,000
29,700
29,000
27,574
27,000
27,500
27,000
25,493
24,586
23,732
67,499
66,695
65,808
65,999
64,964
62,904
97,668
97,056
96,918
274,032
268,974
290,341
310,489
301,022
291,726
300,803
304,121
286,574
301,364
300,986
300,986301,364286,574304,121300,803291,726301,022310,489290,341268,974274,03296,91897,05697,66862,90464,96465,99965,80866,69567,49923,73224,58625,49327,00027,50027,00027,57429,00029,70031,00031,400000
       Long-term Assets Other 
-2,026
0
0
3,740
3,600
3,700
3,700
-1
5,400
5,400
5,400
5,682
5,582
10,000
8,383
211
211
211
211
211
358
354
4,280
-2
4,379
4,329
4,518
-2
1
-1
2
286,574
0
300,986
300,9860286,5742-11-24,5184,3294,379-24,2803543582112112112112118,38310,0005,5825,6825,4005,4005,400-13,7003,7003,6003,74000-2,026
> Total Liabilities 
0
0
0
41,300
38,300
9,700
12,100
13,399
13,300
13,700
13,200
20,276
26,926
26,926
61,821
54,537
51,364
51,126
42,163
45,224
209,390
204,080
399,545
393,059
414,037
429,917
467,645
413,112
416,449
448,038
400,747
357,461
370,797
369,721
369,721370,797357,461400,747448,038416,449413,112467,645429,917414,037393,059399,545204,080209,39045,22442,16351,12651,36454,53761,82126,92626,92620,27613,20013,70013,30013,39912,1009,70038,30041,300000
   > Total Current Liabilities 
0
0
0
22,100
19,200
9,700
9,200
10,639
10,800
9,700
9,300
15,904
21,930
19,550
44,216
39,582
37,329
38,857
30,965
31,278
62,383
61,485
222,626
232,377
248,343
252,445
273,064
305,908
312,647
345,418
301,636
234,937
247,683
256,325
256,325247,683234,937301,636345,418312,647305,908273,064252,445248,343232,377222,62661,48562,38331,27830,96538,85737,32939,58244,21619,55021,93015,9049,3009,70010,80010,6399,2009,70019,20022,100000
       Short-term Debt 
0
0
0
8,900
9,400
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,241
0
0
0013,241000000000000000000000000009,4008,900000
       Accounts payable 
0
0
0
2,000
1,200
4,400
2,000
3,636
3,300
2,700
3,300
3,199
0
0
0
2,368
0
0
0
2,304
0
0
0
34,368
0
0
0
65,691
0
0
0
41,286
0
0
0041,28600065,69100034,3680002,3040002,3680003,1993,3002,7003,3003,6362,0004,4001,2002,000000
       Other Current Liabilities 
0
0
0
4,300
3,200
5,300
7,200
7,003
7,500
7,000
6,000
12,705
21,930
19,550
44,216
37,214
37,329
38,857
30,965
28,974
62,383
61,485
222,626
198,009
248,343
252,445
273,064
240,217
312,647
345,418
301,636
107,517
247,683
256,325
256,325247,683107,517301,636345,418312,647240,217273,064252,445248,343198,009222,62661,48562,38328,97430,96538,85737,32937,21444,21619,55021,93012,7056,0007,0007,5007,0037,2005,3003,2004,300000
   > Long-term Liabilities 
0
0
0
19,200
19,100
0
2,900
2,760
2,500
4,000
3,900
4,372
4,996
7,376
17,605
14,955
14,035
12,269
11,198
13,946
147,007
142,595
176,919
160,682
165,694
177,472
194,581
107,204
103,802
102,620
99,111
122,524
123,114
113,396
113,396123,114122,52499,111102,620103,802107,204194,581177,472165,694160,682176,919142,595147,00713,94611,19812,26914,03514,95517,6057,3764,9964,3723,9004,0002,5002,7602,900019,10019,200000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,198
4,285
147,007
142,595
176,919
160,682
165,694
177,472
194,581
0
0
0
0
0
0
0
0000000194,581177,472165,694160,682176,919142,595147,0074,28511,198000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,269
11,198
11,626
147,007
142,595
176,919
148,611
165,694
177,472
194,581
0
0
102,620
99,110
0
0
0
00099,110102,62000194,581177,472165,694148,611176,919142,595147,00711,62611,19812,26900000000000000000
> Total Stockholder Equity
19,638
0
0
22,400
21,900
84,200
81,300
85,521
80,800
78,600
77,600
79,383
74,110
72,271
391,842
401,676
407,934
410,216
416,338
427,049
753,762
757,725
3,400,457
3,585,074
3,674,037
4,017,325
4,356,087
4,236,451
4,252,064
4,477,356
4,519,456
4,345,212
4,588,283
4,593,251
4,593,2514,588,2834,345,2124,519,4564,477,3564,252,0644,236,4514,356,0874,017,3253,674,0373,585,0743,400,457757,725753,762427,049416,338410,216407,934401,676391,84272,27174,11079,38377,60078,60080,80085,52181,30084,20021,90022,4000019,638
   Common Stock
0
0
0
700
700
1,200
1,200
1,216
1,200
1,200
1,200
1,216
1,216
1,216
1,681
1,681
1,725
1,725
1,725
1,725
1,897
1,897
2,540
2,540
2,540
2,540
2,540
2,540
2,540
2,551
2,551
2,551
2,551
2,251
2,2512,5512,5512,5512,5512,5402,5402,5402,5402,5402,5402,5401,8971,8971,7251,7251,7251,7251,6811,6811,2161,2161,2161,2001,2001,2001,2161,2001,200700700000
   Retained Earnings Total Equity0000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
19,638
0
0
0
0
0
0
633
0
0
0
-130
-349
-415
-878
-285
-1,200
-190
-11
140
-785
-285
8
117,732
190,216
507,032
817,291
581,135
546,929
714,285
708,982
436,777
656,056
632,456
632,456656,056436,777708,982714,285546,929581,135817,291507,032190,216117,7328-285-785140-11-190-1,200-285-878-415-349-13000063300000019,638
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
424,130
425,615
425,615
425,615
751,557
751,557
3,378,985
3,378,985
3,378,985
3,378,985
3,378,985
3,378,985
3,378,985
3,398,121
3,398,121
0
0
0
0003,398,1213,398,1213,378,9853,378,9853,378,9853,378,9853,378,9853,378,9853,378,985751,557751,557425,615425,615425,615424,1300000000000000000
   Treasury Stock0000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
41,100
41,100
92,900
92,900
104,723
105,400
105,400
105,400
106,802
106,583
106,517
415,439
416,032
422,930
425,425
425,604
425,615
750,772
751,272
3,378,985
3,496,717
3,378,985
3,378,985
3,378,985
3,378,985
3,378,985
3,398,121
3,398,121
3,398,121
3,398,121
3,398,421
3,398,4213,398,1213,398,1213,398,1213,398,1213,378,9853,378,9853,378,9853,378,9853,378,9853,496,7173,378,985751,272750,772425,615425,604425,425422,930416,032415,439106,517106,583106,802105,400105,400105,400104,72392,90092,90041,10041,100000



6.3. Balance Sheets

Currency in SEK. All numbers in thousands.




6.4. Cash Flows

Currency in SEK. All numbers in thousands.




6.5. Income Statements

Currency in SEK. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in SEK. All numbers in thousands.

Gross Profit (+$)
totalRevenue882,853
Cost of Revenue-323,966
Gross Profit558,887558,887
 
Operating Income (+$)
Gross Profit558,887
Operating Expense-367,600
Operating Income191,287191,287
 
Operating Expense (+$)
Research Development163,993
Selling General Administrative72,509
Selling And Marketing Expenses167,514
Operating Expense367,600404,016
 
Net Interest Income (+$)
Interest Income64,726
Interest Expense-656
Other Finance Cost-0
Net Interest Income64,070
 
Pretax Income (+$)
Operating Income191,287
Net Interest Income64,070
Other Non-Operating Income Expenses0
Income Before Tax (EBT)268,264114,310
EBIT - interestExpense = 190,631
268,264
234,628
Interest Expense656
Earnings Before Interest and Taxes (EBIT)191,287268,920
Earnings Before Interest and Taxes (EBITDA)246,900
 
After tax Income (+$)
Income Before Tax268,264
Tax Provision-34,292
Net Income From Continuing Ops233,972233,972
Net Income233,972
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses691,566
Total Other Income/Expenses Net76,977-64,070
 

Technical Analysis of Surgical Science Sweden AB
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Surgical Science Sweden AB. The general trend of Surgical Science Sweden AB is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Surgical Science Sweden AB's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Surgical Science Sweden AB.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 140.70 < 146.40 < 154.40.

The bearish price targets are: 111.80.

Tweet this
Surgical Science Sweden AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Surgical Science Sweden AB. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Surgical Science Sweden AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Surgical Science Sweden AB. The current macd is 0.13425809.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Surgical Science Sweden AB price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Surgical Science Sweden AB. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Surgical Science Sweden AB price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Surgical Science Sweden AB Daily Moving Average Convergence/Divergence (MACD) ChartSurgical Science Sweden AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Surgical Science Sweden AB. The current adx is 16.52.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Surgical Science Sweden AB shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Surgical Science Sweden AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Surgical Science Sweden AB. The current sar is 114.97.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Surgical Science Sweden AB Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Surgical Science Sweden AB. The current rsi is 54.98. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Surgical Science Sweden AB Daily Relative Strength Index (RSI) ChartSurgical Science Sweden AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Surgical Science Sweden AB. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Surgical Science Sweden AB price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Surgical Science Sweden AB Daily Stochastic Oscillator ChartSurgical Science Sweden AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Surgical Science Sweden AB. The current cci is 161.54.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Surgical Science Sweden AB Daily Commodity Channel Index (CCI) ChartSurgical Science Sweden AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Surgical Science Sweden AB. The current cmo is 19.09.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Surgical Science Sweden AB Daily Chande Momentum Oscillator (CMO) ChartSurgical Science Sweden AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Surgical Science Sweden AB. The current willr is -25.28089888.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Surgical Science Sweden AB is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Surgical Science Sweden AB Daily Williams %R ChartSurgical Science Sweden AB Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Surgical Science Sweden AB.

Surgical Science Sweden AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Surgical Science Sweden AB. The current atr is 4.79804016.

Surgical Science Sweden AB Daily Average True Range (ATR) ChartSurgical Science Sweden AB Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Surgical Science Sweden AB. The current obv is -4,160,619.

Surgical Science Sweden AB Daily On-Balance Volume (OBV) ChartSurgical Science Sweden AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Surgical Science Sweden AB. The current mfi is 57.15.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Surgical Science Sweden AB Daily Money Flow Index (MFI) ChartSurgical Science Sweden AB Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Surgical Science Sweden AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-05-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-05-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.

6.3. Candlestick Patterns

Surgical Science Sweden AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Surgical Science Sweden AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.977
Ma 20Greater thanMa 50120.135
Ma 50Greater thanMa 100125.862
Ma 100Greater thanMa 200130.741
OpenGreater thanClose128.000
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Surgical Science Sweden AB with someone you think should read this too:
  • Are you bullish or bearish on Surgical Science Sweden AB? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Surgical Science Sweden AB? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Surgical Science Sweden AB

I send you an email if I find something interesting about Surgical Science Sweden AB.


Comments

How you think about this?

Leave a comment

Stay informed about Surgical Science Sweden AB.

Receive notifications about Surgical Science Sweden AB in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.